Smartleaf Asset Management »

Cytek Biosciences shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.2k 1.2k 5.39
2024-06-30 $2.9k 526 5.49

More positions owned by Smartleaf Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Us Quality Grow (QGRW)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Smartleaf Asset Management

Top funds holding Cytek Biosciences

BlackRock
BlackRock
Vanguard Group
Brown Capital Management
Hillhouse Capital Advisors
State Street Corporation
Geode Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management
Morgan Stanley
Bank of New York Mellon
Connor, Clark & Lunn Investment Management

View all funds holding Cytek Biosciences